Authors: Martha Powell, Future Science Group
This month Infectious Diseases Hub is exploring fungal infections. In line with this, we’ve taken a look the increasing concern around Candida auris infections and are asking – is C. auris an emerging threat?
This yeast has been responsible for a growing number of cases since its identification, particularly in the US, in addition to concerns around drug resistance and diagnosis. Find out more about C. auris infection and some of the statistics surrounding it in our video. Should we be concerned? Let us know your thoughts in the comments below.
00.10 – What is Candida auris?
01.10 – Why is it considered an emerging threat?
Information accurate as of July 2017.
- Centers for Disease Control and Prevention. General Information about C. auris. cdc.gov/fungal/diseases/candidiasis/candida-auris-qanda.html (Accessed on 10th July 2017)
- Centers for Disease Control and Prevention. C. auris cdc.gov/fungal/diseases/candidiasis/candida-auris.html (Accessed on 10th July 2017)
- Public Health England. Research and analysis– C. auris identified in England gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-identified-in-england (Accessed on 10th July 2017)
- Chowdhary A, Sharma C, Meis JF. C. auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathogens. 13(5), e1006290 (2017)